All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cancer, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
Do you have Locally-advanced or Metastatic Non-squamous NSCLC With High PD-L1 Expression?
UPlift
A post-marketing study of UPadacitinib evaluating speed of onset and durability of effectiveness for patients with moderate to severe Crohn’s disease for 3 years in the real-world
VECTORS
A study looking at bowel healing for patients
Do you have metastatic , HER2 negative breast cancer?
The purpose of this study is to evaluate the safety and effectiveness of gedatolisib at treating your cancer when combined with other cancer drugs, compared to the standard of care for people with breast cancer.
Whistle-PF a new oral treatment for patients with Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF) or non-IPF Progressive Pulmonary Fibrosis (PPF)
X-ACKT: Clinical trial of a new drug for generalised epilepsy
X-TOLE2: Clinical trial of a new drug for focal epilepsy
Do you have locally advanced or metastatic non-clear cell renal cell carcinoma?
The research project is testing a potential new treatment for nccRCC, called XL092 in a combination with nivolumab.
Do you have advanced ovarian, peritoneal or fallopian tube cancer?
A potential new treatment for advanced ovarian, peritoneal or fallopian tube cancer.
Do you have ovarian, peritoneal or fallopian tube cancer?
The purpose of this study is to test a potential new treatment for ovarian, peritoneal or fallopian tube cancer called ZN-c3-also known as azenosertib.